NEA Management Company
Latest statistics and disclosures from NEA Management Company's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ACLX, TEM, VRNA, RYTM, SVRA, and represent 56.36% of NEA Management Company's stock portfolio.
- Added to shares of these 6 stocks: Mbx Biosciences (+$94M), TEM (+$46M), Zenas Biopharma (+$44M), RGLS (+$10M), Senti Biosciences, IKNA.
- Started 4 new stock positions in Zenas Biopharma, RGLS, Mbx Biosciences, Senti Biosciences.
- Reduced shares in these 5 stocks: Regulus Therapeutics (-$12M), TUYA (-$5.6M), MYND, SNTI, AFMD.
- Sold out of its positions in Regulus Therapeutics, SNTI, TUYA.
- NEA Management Company was a net buyer of stock by $174M.
- NEA Management Company has $1.8B in assets under management (AUM), dropping by 38.11%.
- Central Index Key (CIK): 0001512848
Tip: Access up to 7 years of quarterly data
Positions held by NEA Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for NEA Management Company
NEA Management Company holds 42 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arcellx Common Stock (ACLX) | 17.0 | $313M | 3.7M | 83.51 |
|
|
| Tempus Ai Cl A (TEM) | 16.6 | $305M | +17% | 5.4M | 56.60 |
|
| Verona Pharma Sponsered Ads (VRNA) | 8.8 | $161M | 5.6M | 28.77 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 8.3 | $153M | 2.9M | 52.39 |
|
|
| Savara (SVRA) | 5.7 | $104M | 25M | 4.24 |
|
|
| Coursera (COUR) | 5.6 | $102M | 13M | 7.94 |
|
|
| Mbx Biosciences | 5.1 | $94M | NEW | 3.6M | 25.98 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 4.1 | $75M | 1.6M | 46.98 |
|
|
| Nextnav Common Stock (NN) | 3.3 | $61M | 8.2M | 7.49 |
|
|
| Zenas Biopharma | 2.4 | $44M | NEW | 2.6M | 16.92 |
|
| Monte Rosa Therapeutics (GLUE) | 2.2 | $41M | 7.7M | 5.30 |
|
|
| Trevi Therapeutics (TRVI) | 2.1 | $38M | 11M | 3.34 |
|
|
| Korro Bio (KRRO) | 2.0 | $37M | 1.1M | 33.42 |
|
|
| Phathom Pharmaceuticals (PHAT) | 1.9 | $35M | 2.0M | 18.08 |
|
|
| Aurinia Pharmaceuticals (AUPH) | 1.6 | $29M | 4.0M | 7.33 |
|
|
| CVRX (CVRX) | 1.1 | $21M | 2.4M | 8.81 |
|
|
| Black Diamond Therapeutics (BDTX) | 1.1 | $19M | 4.4M | 4.35 |
|
|
| Celcuity (CELC) | 1.0 | $19M | 1.3M | 14.91 |
|
|
| Gossamer Bio (GOSS) | 1.0 | $18M | 18M | 0.99 |
|
|
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.9 | $16M | 17M | 0.95 |
|
|
| Nkarta (NKTX) | 0.9 | $16M | 3.6M | 4.52 |
|
|
| Oric Pharmaceuticals (ORIC) | 0.8 | $15M | 1.5M | 10.25 |
|
|
| Neuehealth Com New (NEUE) | 0.8 | $14M | 2.7M | 5.22 |
|
|
| Inozyme Pharma (INZY) | 0.7 | $13M | 2.4M | 5.23 |
|
|
| Geron Corporation (GERN) | 0.7 | $13M | 2.8M | 4.54 |
|
|
| Buzzfeed Cl A New (BZFD) | 0.6 | $10M | 3.8M | 2.67 |
|
|
| Regulus Therapeutics (RGLS) | 0.6 | $10M | NEW | 6.5M | 1.57 |
|
| X4 Pharmaceuticals (XFOR) | 0.5 | $10M | 15M | 0.67 |
|
|
| Champions Oncology Com New (CSBR) | 0.5 | $8.3M | 1.7M | 4.87 |
|
|
| Reneo Pharmaceuticals (RPHM) | 0.4 | $8.1M | 4.8M | 1.70 |
|
|
| Desktop Metal Com Cl A (DM) | 0.4 | $6.7M | 1.4M | 4.67 |
|
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.3 | $5.5M | 2.0M | 2.77 |
|
|
| Synlogic Com New (SYBX) | 0.2 | $4.4M | 2.9M | 1.49 |
|
|
| Allakos (ALLK) | 0.2 | $4.0M | 6.1M | 0.65 |
|
|
| Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $3.7M | 2.4M | 1.57 |
|
|
| Marker Therapeutics Com New (MRKR) | 0.2 | $3.0M | 1.1M | 2.82 |
|
|
| Inventiva Sa Ads (IVA) | 0.1 | $2.7M | 1.5M | 1.88 |
|
|
| Affimed Nv Ordinary Shs New (AFMD) | 0.1 | $1.5M | 443k | 3.36 |
|
|
| Ikena Oncology (IKNA) | 0.1 | $1.0M | +5% | 600k | 1.73 |
|
| Senti Biosciences | 0.1 | $1.0M | NEW | 443k | 2.26 |
|
| Wheels Up Experience Com Cl A (UP) | 0.0 | $257k | 106k | 2.42 |
|
|
| Mynd Ai Spon Ads (MYND) | 0.0 | $165k | -94% | 206k | 0.80 |
|
Past Filings by NEA Management Company
SEC 13F filings are viewable for NEA Management Company going back to 2010
- NEA Management Company 2024 Q3 filed Nov. 14, 2024
- NEA Management Company 2024 Q2 filed Aug. 14, 2024
- NEA Management Company 2024 Q1 filed May 15, 2024
- NEA Management Company 2023 Q4 filed Feb. 14, 2024
- NEA Management Company 2023 Q3 filed Nov. 14, 2023
- NEA Management Company 2023 Q2 filed Aug. 11, 2023
- NEA Management Company 2023 Q1 filed May 15, 2023
- NEA Management Company 2022 Q4 filed Feb. 10, 2023
- NEA Management Company 2022 Q3 filed Nov. 14, 2022
- NEA Management Company 2022 Q2 filed Aug. 15, 2022
- NEA Management Company 2022 Q1 filed May 16, 2022
- NEA Management Company 2021 Q4 filed Feb. 14, 2022
- NEA Management Company 2021 Q3 filed Nov. 12, 2021
- NEA Management Company 2021 Q2 filed Aug. 2, 2021
- NEA Management Company 2021 Q1 filed May 14, 2021
- NEA Management Company 2020 Q4 filed Feb. 16, 2021